These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

365 related items for PubMed ID: 9128978

  • 1. CYFRA 21-1 is a useful marker for esophageal squamous cell carcinoma.
    Yamamoto K, Oka M, Hayashi H, Tangoku A, Gondo T, Suzuki T.
    Cancer; 1997 May 01; 79(9):1647-55. PubMed ID: 9128978
    [Abstract] [Full Text] [Related]

  • 2. Utility of the serum tumor markers: CYFRA 21.1, carcinoembryonic antigen (CEA), and squamous cell carcinoma antigen (SCC) in squamous cell lung cancer.
    Tas F, Aydiner A, Topuz E, Yasasever V, Karadeniz A, Saip P.
    J Exp Clin Cancer Res; 2000 Dec 01; 19(4):477-81. PubMed ID: 11277326
    [Abstract] [Full Text] [Related]

  • 3. Clinical usefulness of CYFRA 21-1 for esophageal squamous cell carcinoma in radiation therapy.
    Wakatsuki M, Suzuki Y, Nakamoto S, Ohno T, Ishikawa H, Kiyohara H, Kiyozuka M, Shirai K, Nakayama Y, Nakano T.
    J Gastroenterol Hepatol; 2007 May 01; 22(5):715-9. PubMed ID: 17444861
    [Abstract] [Full Text] [Related]

  • 4. Assessment of serum CYFRA 21-1 in lung cancer.
    Muraki M, Tohda Y, Iwanaga T, Uejima H, Nagasaka Y, Nakajima S.
    Cancer; 1996 Apr 01; 77(7):1274-7. PubMed ID: 8608502
    [Abstract] [Full Text] [Related]

  • 5. The significance of ferritin, lipid-associated sialic acid, CEA, squamous cell carcinoma (SCC) antigen, and CYFRA 21-1 levels in SCC of the head and neck.
    Inal E, Laçin M, Asal K, Ceylan A, Köybaşioğlu A, Ileri F, Uslu SS.
    Kulak Burun Bogaz Ihtis Derg; 2004 Apr 01; 12(1-2):23-30. PubMed ID: 16010093
    [Abstract] [Full Text] [Related]

  • 6. Analysis of serum CYFRA 21-1 concentrations in patients with esophageal cancer.
    Brockmann JG, St Nottberg H, Glodny B, Sprakel B, Senninger N.
    Anticancer Res; 2000 Apr 01; 20(6D):4899-904. PubMed ID: 11332443
    [Abstract] [Full Text] [Related]

  • 7. Study of a new tumor marker, CYFRA 21-1, in squamous cell carcinoma of the cervix, and comparison with squamous cell carcinoma antigen.
    Tsai SC, Kao CH, Wang SJ.
    Neoplasma; 1996 Apr 01; 43(1):27-9. PubMed ID: 8843956
    [Abstract] [Full Text] [Related]

  • 8. Cytokeratin subunit 19 measured by CYFRA 21-1 assay in follow-up of cervical cancer.
    Kainz C, Sliutz G, Mustafa G, Bieglmayr C, Koelbl H, Reinthaller A, Gitsch G.
    Gynecol Oncol; 1995 Mar 01; 56(3):402-5. PubMed ID: 7535720
    [Abstract] [Full Text] [Related]

  • 9. CYFRA 21-1 serum analysis in patients with esophageal cancer.
    Brockmann JG, St Nottberg H, Glodny B, Heinecke A, Senninger NJ.
    Clin Cancer Res; 2000 Nov 01; 6(11):4249-52. PubMed ID: 11106239
    [Abstract] [Full Text] [Related]

  • 10. [A comparison of serum Cyfra 21-1 and SCC AG in the diagnosis of squamous cell esophageal carcinoma].
    Ychou M, Khemissa-Akouz F, Kramar A, Senesse P, Grenier J.
    Bull Cancer; 2001 Oct 01; 88(10):1023-7. PubMed ID: 11713038
    [Abstract] [Full Text] [Related]

  • 11. Cyfra 21-1 in monitoring cervical cancer: a comparison with tissue polypeptide antigen and squamous cell carcinoma antigen.
    Bonfrer JM, Gaarenstroom KN, Korse CM, Van Bunningen BN, Kenemans P.
    Anticancer Res; 1997 Oct 01; 17(3C):2329-34. PubMed ID: 9245246
    [Abstract] [Full Text] [Related]

  • 12. Fuzzy logic-based tumor marker profiles including a new marker tumor M2-PK improved sensitivity to the detection of progression in lung cancer patients.
    Schneider J, Peltri G, Bitterlich N, Neu K, Velcovsky HG, Morr H, Katz N, Eigenbrodt E.
    Anticancer Res; 2003 Oct 01; 23(2A):899-906. PubMed ID: 12820320
    [Abstract] [Full Text] [Related]

  • 13. Cytokeratin 19 fragment CYFRA 21-1 compared with carcinoembryonic antigen, squamous cell carcinoma antigen and neuron-specific enolase in lung cancer. Results of an international multicentre study.
    Ebert W, Dienemann H, Fateh-Moghadam A, Scheulen M, Konietzko N, Schleich T, Bombardieri E.
    Eur J Clin Chem Clin Biochem; 1994 Mar 01; 32(3):189-99. PubMed ID: 7518259
    [Abstract] [Full Text] [Related]

  • 14. CYFRA 21.1 in patients with cervical cancer: comparison with SCC and CEA.
    Molina R, Filella X, Augé JM, Bosch E, Torne A, Pahisa J, Lejarcegui JA, Rovirosa A, Mellado B, Ordi J, Biete A.
    Anticancer Res; 2005 Mar 01; 25(3A):1765-71. PubMed ID: 16033097
    [Abstract] [Full Text] [Related]

  • 15. Optimal combination of seven tumour markers in prediction of advanced stage at first examination of patients with non-small cell lung cancer.
    Ando S, Kimura H, Iwai N, Shima M, Ando M, Kuriyama T.
    Anticancer Res; 2001 Mar 01; 21(4B):3085-92. PubMed ID: 11712815
    [Abstract] [Full Text] [Related]

  • 16. Increased serum midkine concentration as a possible tumor marker in patients with superficial esophageal cancer.
    Shimada H, Nabeya Y, Okazumi S, Matsubara H, Kadomatsu K, Muramatsu T, Ikematsu S, Sakuma S, Ochiai T.
    Oncol Rep; 2003 Mar 01; 10(2):411-4. PubMed ID: 12579281
    [Abstract] [Full Text] [Related]

  • 17. CYFRA 21-1 is not superior to SCC antigen and CEA in head and neck squamous cell cancer.
    Wollenberg B, Jan V, Schmit UM, Hofmann K, Stieber P, Fateh-Moghadam A.
    Anticancer Res; 1996 Mar 01; 16(5B):3117-24. PubMed ID: 8920778
    [Abstract] [Full Text] [Related]

  • 18. Clinical significance of osteopontin in esophageal squamous cell carcinoma: comparison with common tumor markers.
    Shimada Y, Watanabe G, Kawamura J, Soma T, Okabe M, Ito T, Inoue H, Kondo M, Mori Y, Tanaka E, Imamura M.
    Oncology; 2005 Mar 01; 68(2-3):285-92. PubMed ID: 16015046
    [Abstract] [Full Text] [Related]

  • 19. Can initial serum cyfra 21-1, SCC antigen, and TPA levels in squamous cell cervical cancer predict lymph node metastases or prognosis?
    Gaarenstroom KN, Kenter GG, Bonfrer JM, Korse CM, Van de Vijver MJ, Fleuren GJ, Trimbos JB.
    Gynecol Oncol; 2000 Apr 01; 77(1):164-70. PubMed ID: 10739706
    [Abstract] [Full Text] [Related]

  • 20. Tumour markers CEA, NSE, SCC, TPA and CYFRA 21.1 in resectable non-small cell lung cancer.
    Foa P, Fornier M, Miceli R, Seregni E, Santambrogio L, Nosotti M, Cataldo I, Sala M, Caldiera S, Bombardieri E.
    Anticancer Res; 1999 Apr 01; 19(4C):3613-8. PubMed ID: 10629660
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.